| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Nilotinib | CTRPv2 | pan-cancer | AAC | 0.17 | 4e-06 |
| mRNA | PIK-93 | CTRPv2 | pan-cancer | AAC | -0.15 | 4e-05 |
| mRNA | Teniposide | CTRPv2 | pan-cancer | AAC | -0.13 | 0.0008 |
| mRNA | Imatinib | CTRPv2 | pan-cancer | AAC | 0.12 | 0.001 |
| mRNA | PHA-793887 | CTRPv2 | pan-cancer | AAC | -0.095 | 0.003 |
| mRNA | dexamethasone | CTRPv2 | pan-cancer | AAC | -0.1 | 0.003 |
| mRNA | MK-2206 | CTRPv2 | pan-cancer | AAC | -0.11 | 0.003 |
| mRNA | ciclopirox | CTRPv2 | pan-cancer | AAC | -0.097 | 0.004 |
| mRNA | BRD-K20514654 | CTRPv2 | pan-cancer | AAC | 0.14 | 0.005 |
| mRNA | Doxorubicin | gCSI | pan-cancer | AAC | -0.15 | 0.006 |